Exclusive: Inside the staff exodus, plummeting morale that threaten FDA

Agency staff are already struggling, and the future consequences could be more dire.

July 12, 2025 Check out STAT+

Sponsored By

Jose Luis Magana/AP STAT+ | Inside the staff exodus and tanking morale that threaten Makary's FDA FDA staff are already missing deadlines, and the future consequences could be even more dire as workers head for the exits. By Lizzy Lawrence Alex Hogan/STAT MAHA's European food envy is full of contradictions MAHA leaders praise Europe's food rules — but skip its sugar taxes, food labels, and health care. Can selective emulation fix U.S. chronic disease? By Sarah Todd Adobe STAT+ | This Ohio health system tested an AI tool to predict sepsis. Here's how it went Summa Health's early experience with Sepsis Watch, an AI tool, shows how hard it can be to implement AI in a community hospital. By Katie Palmer STAT+ | How Republicans sidelined the health care industry and pushed through historic Medicaid cuts For decades, a number of health industries were untouchable on Capitol Hill. Now, 'there's no such thing as too powerful to be cut,' lobbyist says. By Daniel Payne STAT+ | How Regeneron, maker of a best-selling eye drug, is using patent tactics to try to thwart competition The battle over Eylea has focused interest on a pair of congressional bills that attempt to address how drug companies exploit the U.S. patent system. By Ed Silverman U.S. sees most single-year measles cases since it declared disease eliminated Overwhelming majority of cases found among the unvaccinated, CDC says. Expert says unless vaccination rates increase, measles outbreaks will become common. By Helen Branswell STAT+ | California stem cell agency shutting down unique human tissue biobank California Institute for Regenerative Medicine (CIRM) is closing its biobank, citing high costs and low usage By Jonathan Wosen Opinion: ER docs are too quick to assume cannabis users are experiencing this rare side effect Cannabis hyperemesis syndrome, while real and certainly debilitating, is relatively uncommon and requires a careful diagnosis. By Jordan Tishler

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser